Caplin Point Laboratories informs about press release
Caplin Point Laboratories has informed that it enclosed Press Release on the company’s Subsidiary, Caplin Steriles, getting USFDA approval for its ANDA Linezolid Injection 600 mg/ 300 mL (2 mg/mL) Single Dose Infusion Bags.
The above information is a part of company’s filings submitted to BSE.
